Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7379 |
Intermediate Similarity |
NPD1058 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD1313 |
Approved |
0.6788 |
Remote Similarity |
NPD6074 |
Clinical (unspecified phase) |
0.6766 |
Remote Similarity |
NPD1333 |
Phase 3 |
0.6706 |
Remote Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.6705 |
Remote Similarity |
NPD2930 |
Clinical (unspecified phase) |
0.6689 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.6688 |
Remote Similarity |
NPD7158 |
Phase 1 |
0.6687 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD5962 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD3378 |
Clinical (unspecified phase) |
0.6648 |
Remote Similarity |
NPD7023 |
Clinical (unspecified phase) |
0.6647 |
Remote Similarity |
NPD1015 |
Phase 2 |
0.6647 |
Remote Similarity |
NPD2875 |
Clinical (unspecified phase) |
0.6647 |
Remote Similarity |
NPD1016 |
Phase 2 |
0.6627 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.6618 |
Remote Similarity |
NPD8836 |
Approved |
0.6609 |
Remote Similarity |
NPD3341 |
Clinical (unspecified phase) |
0.6606 |
Remote Similarity |
NPD2927 |
Phase 3 |
0.6554 |
Remote Similarity |
NPD9408 |
Phase 3 |
0.6538 |
Remote Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.6534 |
Remote Similarity |
NPD4649 |
Clinical (unspecified phase) |
0.6533 |
Remote Similarity |
NPD9633 |
Phase 3 |
0.6529 |
Remote Similarity |
NPD1215 |
Discontinued |
0.6524 |
Remote Similarity |
NPD6129 |
Phase 2 |
0.6519 |
Remote Similarity |
NPD4240 |
Approved |
0.6519 |
Remote Similarity |
NPD3419 |
Clinical (unspecified phase) |
0.6505 |
Remote Similarity |
NPD6816 |
Phase 3 |
0.6491 |
Remote Similarity |
NPD2333 |
Discontinued |
0.649 |
Remote Similarity |
NPD248 |
Discontinued |
0.6471 |
Remote Similarity |
NPD5269 |
Clinical (unspecified phase) |
0.6461 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.6461 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.6457 |
Remote Similarity |
NPD7111 |
Discontinued |
0.6455 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.6437 |
Remote Similarity |
NPD3799 |
Suspended |
0.6433 |
Remote Similarity |
NPD6794 |
Approved |
0.6429 |
Remote Similarity |
NPD6761 |
Discontinued |
0.642 |
Remote Similarity |
NPD5730 |
Phase 2 |
0.642 |
Remote Similarity |
NPD40 |
Phase 2 |
0.641 |
Remote Similarity |
NPD799 |
Phase 1 |
0.6393 |
Remote Similarity |
NPD7722 |
Suspended |
0.6392 |
Remote Similarity |
NPD4352 |
Phase 1 |
0.6389 |
Remote Similarity |
NPD2793 |
Discontinued |
0.6389 |
Remote Similarity |
NPD4902 |
Discontinued |
0.6384 |
Remote Similarity |
NPD5508 |
Phase 1 |
0.638 |
Remote Similarity |
NPD4568 |
Phase 2 |
0.6374 |
Remote Similarity |
NPD8120 |
Approved |
0.6374 |
Remote Similarity |
NPD8121 |
Phase 3 |
0.6369 |
Remote Similarity |
NPD5463 |
Clinical (unspecified phase) |
0.6344 |
Remote Similarity |
NPD5462 |
Discontinued |
0.6343 |
Remote Similarity |
NPD7006 |
Approved |
0.6337 |
Remote Similarity |
NPD2647 |
Phase 3 |
0.6335 |
Remote Similarity |
NPD7323 |
Phase 2 |
0.6329 |
Remote Similarity |
NPD3696 |
Approved |
0.6329 |
Remote Similarity |
NPD3695 |
Approved |
0.6325 |
Remote Similarity |
NPD2524 |
Discontinued |
0.6323 |
Remote Similarity |
NPD4763 |
Clinical (unspecified phase) |
0.6304 |
Remote Similarity |
NPD3431 |
Approved |
0.6304 |
Remote Similarity |
NPD6619 |
Phase 3 |
0.6304 |
Remote Similarity |
NPD3430 |
Approved |
0.6298 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.6298 |
Remote Similarity |
NPD6721 |
Phase 1 |
0.6286 |
Remote Similarity |
NPD5324 |
Clinical (unspecified phase) |
0.6273 |
Remote Similarity |
NPD171 |
Discontinued |
0.6272 |
Remote Similarity |
NPD5300 |
Clinical (unspecified phase) |
0.6271 |
Remote Similarity |
NPD3041 |
Approved |
0.6257 |
Remote Similarity |
NPD2526 |
Phase 2 |
0.6257 |
Remote Similarity |
NPD1637 |
Clinical (unspecified phase) |
0.6257 |
Remote Similarity |
NPD2523 |
Phase 2 |
0.6257 |
Remote Similarity |
NPD5806 |
Clinical (unspecified phase) |
0.625 |
Remote Similarity |
NPD5969 |
Clinical (unspecified phase) |
0.6243 |
Remote Similarity |
NPD2478 |
Clinical (unspecified phase) |
0.6236 |
Remote Similarity |
NPD1892 |
Phase 2 |
0.6236 |
Remote Similarity |
NPD3409 |
Phase 1 |
0.6236 |
Remote Similarity |
NPD1893 |
Phase 2 |
0.6229 |
Remote Similarity |
NPD6828 |
Phase 2 |
0.6229 |
Remote Similarity |
NPD6827 |
Clinical (unspecified phase) |
0.6223 |
Remote Similarity |
NPD6468 |
Clinical (unspecified phase) |
0.6223 |
Remote Similarity |
NPD6469 |
Phase 3 |
0.6218 |
Remote Similarity |
NPD7445 |
Phase 1 |
0.6218 |
Remote Similarity |
NPD2450 |
Phase 2 |
0.6218 |
Remote Similarity |
NPD2452 |
Phase 2 |
0.6218 |
Remote Similarity |
NPD2453 |
Phase 2 |
0.6218 |
Remote Similarity |
NPD2451 |
Phase 2 |
0.6216 |
Remote Similarity |
NPD6577 |
Clinical (unspecified phase) |
0.6216 |
Remote Similarity |
NPD4615 |
Phase 2 |
0.6216 |
Remote Similarity |
NPD2839 |
Phase 2 |
0.6215 |
Remote Similarity |
NPD5843 |
Discontinued |
0.6215 |
Remote Similarity |
NPD2406 |
Clinical (unspecified phase) |
0.6205 |
Remote Similarity |
NPD6192 |
Phase 3 |
0.6198 |
Remote Similarity |
NPD5012 |
Phase 2 |
0.6186 |
Remote Similarity |
NPD4612 |
Discontinued |
0.6185 |
Remote Similarity |
NPD3889 |
Approved |
0.6175 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.6168 |
Remote Similarity |
NPD3107 |
Discontinued |
0.6166 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.6166 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.6159 |
Remote Similarity |
NPD4183 |
Phase 3 |
0.6159 |
Remote Similarity |
NPD4182 |
Phase 3 |
0.6158 |
Remote Similarity |
NPD7297 |
Phase 2 |
0.6158 |
Remote Similarity |
NPD6849 |
Phase 2 |
0.6158 |
Remote Similarity |
NPD6850 |
Phase 2 |
0.6154 |
Remote Similarity |
NPD2646 |
Discontinued |
0.6154 |
Remote Similarity |
NPD546 |
Clinical (unspecified phase) |
0.6133 |
Remote Similarity |
NPD306 |
Approved |
0.6133 |
Remote Similarity |
NPD4441 |
Phase 2 |
0.6131 |
Remote Similarity |
NPD1257 |
Approved |
0.6126 |
Remote Similarity |
NPD6151 |
Phase 2 |
0.6126 |
Remote Similarity |
NPD4318 |
Clinical (unspecified phase) |
0.6125 |
Remote Similarity |
NPD193 |
Suspended |
0.6122 |
Remote Similarity |
NPD8831 |
Approved |
0.6122 |
Remote Similarity |
NPD8833 |
Approved |
0.612 |
Remote Similarity |
NPD5642 |
Approved |
0.612 |
Remote Similarity |
NPD5682 |
Phase 3 |
0.612 |
Remote Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.612 |
Remote Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.6117 |
Remote Similarity |
NPD3362 |
Clinical (unspecified phase) |
0.6111 |
Remote Similarity |
NPD174 |
Discontinued |
0.6108 |
Remote Similarity |
NPD2818 |
Discontinued |
0.6108 |
Remote Similarity |
NPD5145 |
Clinical (unspecified phase) |
0.6105 |
Remote Similarity |
NPD1288 |
Clinical (unspecified phase) |
0.6103 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.6103 |
Remote Similarity |
NPD6520 |
Phase 3 |
0.6103 |
Remote Similarity |
NPD6521 |
Phase 3 |
0.6102 |
Remote Similarity |
NPD5996 |
Clinical (unspecified phase) |
0.6092 |
Remote Similarity |
NPD509 |
Phase 3 |
0.6091 |
Remote Similarity |
NPD4863 |
Approved |
0.6087 |
Remote Similarity |
NPD6418 |
Phase 1 |
0.6084 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.6071 |
Remote Similarity |
NPD3860 |
Discontinued |
0.6071 |
Remote Similarity |
NPD1029 |
Clinical (unspecified phase) |
0.6071 |
Remote Similarity |
NPD1030 |
Approved |
0.6071 |
Remote Similarity |
NPD1027 |
Approved |
0.6062 |
Remote Similarity |
NPD2364 |
Suspended |
0.6059 |
Remote Similarity |
NPD4854 |
Phase 3 |
0.6054 |
Remote Similarity |
NPD7504 |
Discontinued |
0.6053 |
Remote Similarity |
NPD5885 |
Approved |
0.6051 |
Remote Similarity |
NPD3905 |
Phase 3 |
0.6049 |
Remote Similarity |
NPD185 |
Approved |
0.6042 |
Remote Similarity |
NPD4142 |
Discontinued |
0.6036 |
Remote Similarity |
NPD3612 |
Phase 2 |
0.6033 |
Remote Similarity |
NPD2963 |
Phase 1 |
0.6032 |
Remote Similarity |
NPD2960 |
Clinical (unspecified phase) |
0.6024 |
Remote Similarity |
NPD1690 |
Clinical (unspecified phase) |
0.6022 |
Remote Similarity |
NPD4716 |
Approved |
0.6022 |
Remote Similarity |
NPD1873 |
Clinical (unspecified phase) |
0.6022 |
Remote Similarity |
NPD702 |
Clinical (unspecified phase) |
0.6019 |
Remote Similarity |
NPD6352 |
Phase 2 |
0.601 |
Remote Similarity |
NPD5486 |
Discontinued |
0.6 |
Remote Similarity |
NPD2880 |
Discontinued |
0.6 |
Remote Similarity |
NPD1303 |
Phase 1 |
0.6 |
Remote Similarity |
NPD4023 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD2731 |
Phase 2 |
0.6 |
Remote Similarity |
NPD7988 |
Suspended |
0.6 |
Remote Similarity |
NPD1807 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD6271 |
Approved |
0.599 |
Remote Similarity |
NPD6470 |
Phase 3 |
0.5989 |
Remote Similarity |
NPD1895 |
Discontinued |
0.5989 |
Remote Similarity |
NPD7709 |
Discontinued |
0.5989 |
Remote Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.5989 |
Remote Similarity |
NPD1674 |
Clinical (unspecified phase) |
0.5989 |
Remote Similarity |
NPD1675 |
Phase 1 |
0.598 |
Remote Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.598 |
Remote Similarity |
NPD7164 |
Discontinued |
0.598 |
Remote Similarity |
NPD2902 |
Phase 2 |
0.5978 |
Remote Similarity |
NPD2868 |
Clinical (unspecified phase) |
0.5978 |
Remote Similarity |
NPD4298 |
Clinical (unspecified phase) |
0.5976 |
Remote Similarity |
NPD250 |
Approved |
0.5976 |
Remote Similarity |
NPD166 |
Approved |
0.5976 |
Remote Similarity |
NPD249 |
Approved |
0.5972 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.5968 |
Remote Similarity |
NPD2728 |
Approved |
0.5968 |
Remote Similarity |
NPD2729 |
Approved |
0.5968 |
Remote Similarity |
NPD2730 |
Approved |
0.5967 |
Remote Similarity |
NPD3432 |
Approved |
0.5966 |
Remote Similarity |
NPD4213 |
Clinical (unspecified phase) |
0.5966 |
Remote Similarity |
NPD3361 |
Phase 1 |
0.5965 |
Remote Similarity |
NPD3405 |
Phase 3 |
0.596 |
Remote Similarity |
NPD4990 |
Clinical (unspecified phase) |
0.5949 |
Remote Similarity |
NPD7103 |
Approved |
0.5948 |
Remote Similarity |
NPD9084 |
Phase 2 |
0.5947 |
Remote Similarity |
NPD7935 |
Phase 2 |
0.5946 |
Remote Similarity |
NPD5757 |
Discontinued |
0.5944 |
Remote Similarity |
NPD5943 |
Clinical (unspecified phase) |
0.5941 |
Remote Similarity |
NPD2128 |
Phase 1 |
0.593 |
Remote Similarity |
NPD2150 |
Discontinued |
0.593 |
Remote Similarity |
NPD3265 |
Phase 1 |
0.5928 |
Remote Similarity |
NPD2881 |
Approved |
0.5928 |
Remote Similarity |
NPD2807 |
Discontinued |
0.5928 |
Remote Similarity |
NPD548 |
Clinical (unspecified phase) |
0.5928 |
Remote Similarity |
NPD2879 |
Approved |
0.5918 |
Remote Similarity |
NPD5458 |
Discontinued |
0.5916 |
Remote Similarity |
NPD3830 |
Phase 1 |
0.5915 |
Remote Similarity |
NPD3706 |
Clinical (unspecified phase) |
0.5914 |
Remote Similarity |
NPD7394 |
Phase 2 |
0.5912 |
Remote Similarity |
NPD4155 |
Approved |
0.5912
|
Remote Similarity |
NPD9484 |
Clinical (unspecified phase) |